XASXBUB
Market cap58mUSD
Jan 08, Last price
0.11AUD
1D
5.00%
1Q
-22.22%
Name
Bubs Australia Ltd
Chart & Performance
Profile
Bubs Australia Limited, together with its subsidiaries, engages in the production and sale of various infant nutrition products in Australia, China, and internationally. The company offers organic baby food, goat milk, organic cow's milk infant and supreme formula, adult goat milk powder, and fresh dairy products, as well as pouches, cereals and porridges, rusks, and snacks under the Bubs brand name. It also provides children's vitamin and mineral supplement products under the Vita Bubs name; canning services for nutritional dairy products; and holds IP and trademarks. The company was incorporated in 1993 and is based in Frenchs Forest, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 79,704 32.60% | 60,111 -32.68% | 89,297 127.15% | |||||||
Cost of revenue | 99,679 | 126,552 | 103,363 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (19,975) | (66,442) | (14,066) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 500 | 868 | 76 | |||||||
Tax Rate | ||||||||||
NOPAT | (20,475) | (67,310) | (14,143) | |||||||
Net income | (20,989) -80.63% | (108,353) 852.34% | (11,378) -84.78% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 15,681 | 58,969 | ||||||||
BB yield | -14.49% | -44.31% | ||||||||
Debt | ||||||||||
Debt current | 6,011 | 2,679 | 2,616 | |||||||
Long-term debt | 2,700 | 3,453 | 4,606 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 366 | 275 | 236 | |||||||
Net debt | (9,371) | (20,037) | (9,226) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (26,328) | (46,493) | (9,374) | |||||||
CAPEX | (174) | (247) | (557) | |||||||
Cash from investing activities | (190) | (4,247) | (1,555) | |||||||
Cash from financing activities | 17,988 | 60,482 | (643) | |||||||
FCF | (27,114) | (48,292) | (29,705) | |||||||
Balance | ||||||||||
Cash | 17,523 | 26,053 | 16,311 | |||||||
Long term investments | 558 | 117 | 137 | |||||||
Excess cash | 14,097 | 23,164 | 11,983 | |||||||
Stockholders' equity | 36,872 | 41,680 | 88,210 | |||||||
Invested Capital | 30,139 | 23,073 | 81,381 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 832,290 | 739,265 | 623,004 | |||||||
Price | 0.13 -27.78% | 0.18 -69.75% | 0.60 36.80% | |||||||
Market cap | 108,198 -18.69% | 133,068 -64.11% | 370,729 38.87% | |||||||
EV | 98,827 | 113,031 | 361,503 | |||||||
EBITDA | (18,802) | (63,720) | (10,999) | |||||||
EV/EBITDA | ||||||||||
Interest | 241 | 452 | 425 | |||||||
Interest/NOPBT |